Guy Laurent

9.3k total citations
197 papers, 7.3k citations indexed

About

Guy Laurent is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Guy Laurent has authored 197 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Molecular Biology, 54 papers in Oncology and 41 papers in Immunology. Recurrent topics in Guy Laurent's work include Sphingolipid Metabolism and Signaling (37 papers), Lymphoma Diagnosis and Treatment (28 papers) and Chronic Lymphocytic Leukemia Research (27 papers). Guy Laurent is often cited by papers focused on Sphingolipid Metabolism and Signaling (37 papers), Lymphoma Diagnosis and Treatment (28 papers) and Chronic Lymphocytic Leukemia Research (27 papers). Guy Laurent collaborates with scholars based in France, Belgium and United States. Guy Laurent's co-authors include Jean‐Pierre Jaffrézou, Anne Quillet‐Mary, Christine Bezombes, Thierry Levade, Paul M. Tulkens, Véronique Mansat‐De Mas, Denis Nonclercq, Ali Bettaı̈eb, Christine Bordier and Loïc Ysebaert and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Guy Laurent

196 papers receiving 7.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Guy Laurent 3.9k 1.8k 1.5k 1.2k 734 197 7.3k
Aviv Gazit 5.3k 1.4× 3.3k 1.8× 1.3k 0.8× 550 0.5× 1.0k 1.4× 99 9.7k
Brian Leber 6.3k 1.6× 1.3k 0.7× 1.2k 0.8× 680 0.6× 1.6k 2.2× 196 9.5k
Alexandru Almasan 4.4k 1.1× 1.9k 1.0× 951 0.6× 502 0.4× 351 0.5× 96 6.5k
Joel M. Reid 4.5k 1.2× 3.0k 1.6× 656 0.4× 743 0.6× 545 0.7× 270 10.0k
Richard B. Lock 5.1k 1.3× 2.8k 1.6× 1.0k 0.7× 659 0.6× 1.6k 2.2× 260 8.7k
Agostino Tafuri 4.3k 1.1× 1.7k 0.9× 2.3k 1.5× 508 0.4× 2.0k 2.7× 160 8.3k
Paul A. Clarke 5.1k 1.3× 2.6k 1.4× 746 0.5× 1.2k 1.0× 279 0.4× 139 8.4k
Didier Decaudin 3.6k 0.9× 1.8k 1.0× 1.2k 0.8× 1.2k 1.0× 256 0.3× 148 7.0k
Jordan S. Fridman 3.6k 0.9× 2.0k 1.1× 700 0.5× 458 0.4× 1.0k 1.4× 41 6.0k
Patrick Auberger 6.5k 1.7× 2.1k 1.2× 1.9k 1.2× 494 0.4× 1.1k 1.5× 193 10.5k

Countries citing papers authored by Guy Laurent

Since Specialization
Citations

This map shows the geographic impact of Guy Laurent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Laurent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Laurent more than expected).

Fields of papers citing papers by Guy Laurent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Laurent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Laurent. The network helps show where Guy Laurent may publish in the future.

Co-authorship network of co-authors of Guy Laurent

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Laurent. A scholar is included among the top collaborators of Guy Laurent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Laurent. Guy Laurent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mounié, Michaël, Nadège Costa, Fabien Despas, et al.. (2019). Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France. Journal of Medical Economics. 23(3). 235–242. 7 indexed citations
2.
Laurent, Guy, et al.. (2017). A diagnostic protocol designed for determining allergic causes in patients with blood eosinophilia. Military Medical Research. 4(1). 15–15. 6 indexed citations
3.
Kindt, Nadège, Fabrice Journé, Guy Laurent, & Sven Saussez. (2016). Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets. Oncology Letters. 12(4). 2247–2253. 45 indexed citations
4.
Foss, Francine M., Ranjana H. Advani, Madeleine Duvic, et al.. (2014). A Phase II trial of Belinostat ( PXD 101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma. British Journal of Haematology. 168(6). 811–819. 161 indexed citations
5.
Alcantara, Marion, Jehan Dupuis, Sylvain Mareschal, et al.. (2014). PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 42(2). 215–221. 23 indexed citations
6.
Kindt, Nadège, Jérôme R. Lechien, Denis Nonclercq, Guy Laurent, & Sven Saussez. (2014). Involvement of CD74 in head and neck squamous cell carcinomas. Journal of Cancer Research and Clinical Oncology. 140(6). 937–947. 29 indexed citations
7.
Viaud, Julien, Loïc Ysebaert, Fanny Lafouresse, et al.. (2013). CIP4 Controls CCL19-Driven Cell Steering and Chemotaxis in Chronic Lymphocytic Leukemia. Cancer Research. 73(11). 3412–3424. 15 indexed citations
8.
Gravelle, Pauline, Christine Jean, J Familiadès, et al.. (2013). Cell Growth in Aggregates Determines Gene Expression, Proliferation, Survival, Chemoresistance, and Sensitivity to Immune Effectors in Follicular Lymphoma. American Journal Of Pathology. 184(1). 282–295. 29 indexed citations
9.
Jean, Christine, Naïs Prade-Houdellier, Loïc Ysebaert, et al.. (2009). Epidermal Growth Factor Receptor/β-Catenin/T-Cell Factor 4/Matrix Metalloproteinase 1: A New Pathway for Regulating Keratinocyte Invasiveness after UVA Irradiation. Cancer Research. 69(8). 3291–3299. 26 indexed citations
10.
Saussez, Sven, Daniel Glinoer, Gilbert Chantrain, et al.. (2008). Serum Galectin-1 and Galectin-3 Levels in Benign and Malignant Nodular Thyroid Disease. Thyroid. 18(7). 705–712. 71 indexed citations
11.
Jean, Christine, et al.. (2007). Epidermal Growth Factor Receptor Pathway Mitigates UVA-Induced G2/M Arrest in Keratinocyte Cells. Journal of Investigative Dermatology. 127(10). 2418–2424. 16 indexed citations
12.
Jacquot, Yves, Ioanna Laı̈os, Denis Nonclercq, et al.. (2007). Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells. Bioorganic & Medicinal Chemistry. 15(6). 2269–2282. 39 indexed citations
13.
Canitrot, Yvan, Guy Laurent, Catherine Astarie‐Dequeker, et al.. (2006). Enhanced expression and activity of DNA polymerase beta in chronic myelogenous leukemia.. PubMed. 26(1B). 523–5. 23 indexed citations
14.
Terrisse, Anne-Dominique, et al.. (2004). Cytoprotective Effect of Glucosylceramide Synthase Inhibition against Daunorubicin-induced Apoptosis in Human Leukemic Cell Lines. Journal of Biological Chemistry. 279(18). 18256–18261. 32 indexed citations
15.
16.
17.
Jaffrézou, Jean‐Pierre, et al.. (1998). Positive feedback control of neutral sphingomyelinase activity by ceramide. The FASEB Journal. 12(11). 999–1006. 70 indexed citations
18.
Bruno, Alain, Guy Laurent, D. Averbeck, et al.. (1998). Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death and Differentiation. 5(2). 172–182. 62 indexed citations
19.
Lautier, Dominique, Jean‐Denis Bailly, Cécile Demur, et al.. (1997). Altered intracellular distribution of daunorubicin in immature acute myeloid leukemia cells. International Journal of Cancer. 71(2). 292–299. 25 indexed citations
20.
Forni, M, Françoise Huguet, Pierre Canal, et al.. (1991). Phase I/II pharmacokinetic study of mitoxantrone by continuous venous infusion in patients with solid tumours and lymphoproliferative diseases. European Journal of Cancer and Clinical Oncology. 27(6). 735–739. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aviv Gazit Breakdown of academic impact, for papers by Brian Leber Breakdown of academic impact, for papers by Alexandru Almasan Breakdown of academic impact, for papers by Joel M. Reid Breakdown of academic impact, for papers by Richard B. Lock Breakdown of academic impact, for papers by Agostino Tafuri Breakdown of academic impact, for papers by Paul A. Clarke Breakdown of academic impact, for papers by Didier Decaudin Breakdown of academic impact, for papers by Jordan S. Fridman Breakdown of academic impact, for papers by Patrick Auberger
Rankless by CCL
2026